Valeritas, Inc.

Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes
Health, Medical, & Dental Supplies and Equipment

Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes

BRIDGEWATER, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today the publication last week of a manuscript...

Read More »
Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets
Health, Medical, & Dental Supplies and Equipment

Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets

BRIDGEWATER, N.J., April 30, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, last week presented positive findings from a new study during the poster...

Read More »
Health, Medical, & Dental Supplies and Equipment

Valeritas Teams with Glooko as its Preferred Data Management Partner for V-Go® SIM™

BRIDGEWATER, N.J., April 20, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it has entered into an agreement...

Read More »
Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration Algorithm
Health, Medical, & Dental Supplies and Equipment

Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration Algorithm

BRIDGEWATER, N.J., Feb. 15, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it presented positive findings from its...

Read More »
V-Go Wearable Insulin Delivery Device features a cartridge made from TOPAS® COC.
Health, Medical, & Dental Supplies and Equipment

V-Go Wearable Insulin Delivery Device features a cartridge made from TOPAS® COC.

The V-Go Wearable Insulin Delivery device from Valeritas Holdings, Inc. offers patients with Type 2 diabetes an option to eliminate the need for taking multiple daily shots. The device is worn like a patch and features an injection molded cartridge of TOPAS cyclic olefin copolymer. The wearable basal is small and lightweight, and also intended to be worn under clothing. The V-Go device is fully...

Read More »
Valeritas Announces its V-Go® Wearable Insulin Delivery Device is Now Available in Puerto Rico
Health, Medical, & Dental Supplies and Equipment

Valeritas Announces its V-Go® Wearable Insulin Delivery Device is Now Available in Puerto Rico

BRIDGEWATER, N.J., Jan. 17, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today that its V-Go® Wearable Insulin Delivery device is...

Read More »
Valeritas' V-Go® Wearable Insulin Delivery Device, Combined with a Simplified Insulin Titration Algorithm, Demonstrates Significant Reductions in A1C and Insulin Requirements in Patients with Type 2 Diabetes
Health, Medical, & Dental Supplies and Equipment

Valeritas' V-Go® Wearable Insulin Delivery Device, Combined with a Simplified Insulin Titration Algorithm, Demonstrates Significant Reductions in A1C and Insulin Requirements in Patients with Type 2 Diabetes

BRIDGEWATER, N.J., Nov. 03, 2017 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies, announced today positive findings from a analysis conducted combining its V-Go® Wearable Basal plus Bolus Insulin Delivery Device with a weekly physician-driven,...

Read More »
Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes
Health, Medical, & Dental Supplies and Equipment

Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes

BRIDGEWATER, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today the publication last week of a manuscript...

Read More »
Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets
Health, Medical, & Dental Supplies and Equipment

Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets

BRIDGEWATER, N.J., April 30, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, last week presented positive findings from a new study during the poster...

Read More »
Health, Medical, & Dental Supplies and Equipment

Valeritas Teams with Glooko as its Preferred Data Management Partner for V-Go® SIM™

BRIDGEWATER, N.J., April 20, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it has entered into an agreement...

Read More »
Company News

Valeritas Announces V-Go® Distribution Agreement in Italy with Movi SpA

BRIDGEWATER, N.J., Feb. 22, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, today announced it has signed an exclusive distribution agreement...

Read More »
Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration Algorithm
Health, Medical, & Dental Supplies and Equipment

Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration Algorithm

BRIDGEWATER, N.J., Feb. 15, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it presented positive findings from its...

Read More »
V-Go Wearable Insulin Delivery Device features a cartridge made from TOPAS® COC.
Health, Medical, & Dental Supplies and Equipment

V-Go Wearable Insulin Delivery Device features a cartridge made from TOPAS® COC.

The V-Go Wearable Insulin Delivery device from Valeritas Holdings, Inc. offers patients with Type 2 diabetes an option to eliminate the need for taking multiple daily shots. The device is worn like a patch and features an injection molded cartridge of TOPAS cyclic olefin copolymer. The wearable basal is small and lightweight, and also intended to be worn under clothing. The V-Go device is fully...

Read More »
Valeritas Announces its V-Go® Wearable Insulin Delivery Device is Now Available in Puerto Rico
Health, Medical, & Dental Supplies and Equipment

Valeritas Announces its V-Go® Wearable Insulin Delivery Device is Now Available in Puerto Rico

BRIDGEWATER, N.J., Jan. 17, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today that its V-Go® Wearable Insulin Delivery device is...

Read More »
Valeritas' V-Go® Wearable Insulin Delivery Device, Combined with a Simplified Insulin Titration Algorithm, Demonstrates Significant Reductions in A1C and Insulin Requirements in Patients with Type 2 Diabetes
Health, Medical, & Dental Supplies and Equipment

Valeritas' V-Go® Wearable Insulin Delivery Device, Combined with a Simplified Insulin Titration Algorithm, Demonstrates Significant Reductions in A1C and Insulin Requirements in Patients with Type 2 Diabetes

BRIDGEWATER, N.J., Nov. 03, 2017 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies, announced today positive findings from a analysis conducted combining its V-Go® Wearable Basal plus Bolus Insulin Delivery Device with a weekly physician-driven,...

Read More »

All Topics